CN103830215A - Skin-disease targeted medicine adopting acetic acid and vaseline as main components - Google Patents
Skin-disease targeted medicine adopting acetic acid and vaseline as main components Download PDFInfo
- Publication number
- CN103830215A CN103830215A CN201310353452.3A CN201310353452A CN103830215A CN 103830215 A CN103830215 A CN 103830215A CN 201310353452 A CN201310353452 A CN 201310353452A CN 103830215 A CN103830215 A CN 103830215A
- Authority
- CN
- China
- Prior art keywords
- acetic acid
- skin
- vaseline
- medicine
- dermatosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a skin-disease targeted medicine adopting acetic acid and vaseline as main components. The principle of the skin-disease targeted medicine is as follows: by utilization of the characteristics that acetic acid with proper concentration has poor permeability to normal cells and strong permeability to pathological cells and utilization of the volatility of acetic acid, the targeted administration to the pathological cells can be achieved; the reaction time is controlled by using a method for painting vaseline, and foreign matters entering the skin and pathological cells are taken out by utilizing the corrosivity of acetic acid as a means, so that the purpose of treating the skin disease is achieved.
Description
Technical field
The present invention relates to a kind of composite medicine, described composite medicine is all common drugs, as long as using method is correct, drug safety is reliable.
Background technology
This medicine has solved the outbreak problem repeatedly in treating skin disease process, and it also has prior radical-ability except having broad spectrum activity, once cure never recurrence.
Summary of the invention
The present invention relates to a kind of composite medicine, described composite medicine is all common drugs, as long as using method is correct, drug safety is reliable.
The exclusivity of this medicine shows:
1 has fundamentally changed people to dermopathic understanding, dermatosis is exactly to enter skin because of foreign body, the living environment that causes cell changes and the common inflammation that causes, eating dozen antibiotic medicine all runs affairs, but because foreign body does not take out, just repeatedly, this medicine has fundamentally solved the problem that dermatosis is shown effect repeatedly in drug withdrawal, treat in dermopathic process with this medicine at you, you can see dermopathic formation and development process clearly.
2 have realized dermopathic radical cure, because skin has infiltration and absorption function, pesticide is sprinkled upon on skin, can fall ill soon, or causing death, dermatosis is exactly that relatively active chemical foreign body enters the common inflammation of the one causing after skin or presentation, and same foreign body enters people's position difference, the form difference of performance; Depth difference, the form of performance is also different, and the form of the different in kind performance of chemistry is more different, utilizes the corrosivity of acetic acid foreign body, once cure never recurrence.
The practicality of this medicine shows:
Described in 1, composite medicine is all common drugs, as long as using method is correct, drug safety is reliable.2 utilize debita spissitudo acetic acid poor to normal cell permeability, the feature strong to the permeability of sick cell.Utilize the volatility of acetic acid, can reach the targeting medication to sick cell.With method control response time of thickness of smearing vaseline, utilize the corrosivity of acetic acid, take out entering the foreign body of skin and the cell of pathological changes, realize the dermopathic object of radical cure.
The characteristic of this medicine shows:
When in use, smear vaseline after first smearing acetic acid.In all documents and method, all there is no such Therapeutic Method.
Embodiment
Key word:
Dermatosis: all and different skin phenomenon of normal skin presentation is all dermatosis.
Dermatosis as referred to herein is the skin presentations such as graduated dial skin ulcer, acne, tinea, verruca vulgaris, black naevus, beriberi, leukoderma, callosity, clavus, part cancer.
For the albinism causing due to gene, by inject or purpura, scleroderma etc. that diet allergy causes not within dermatosis mentioned herein.
Treating for skin disease principle is:
Utilize debita spissitudo acetic acid poor to normal cell permeability, the feature strong to the permeability of sick cell.
Utilize the volatility of acetic acid simultaneously, can reach the targeting medication to sick cell.
With method control response time of thickness of smearing vaseline, the corrosivity of utilizing acetic acid is means, takes out entering the foreign body of skin and the cell of pathological changes, realizes the dermopathic object of radical cure.Risk analysis:
One medical ventolin: the medicine of smearing as a kind of external, its safety, people have used for many years, it is reliable, we do not have necessity of what worry yet, and the chemical reaction after its contact acetic acid, also has nothing impeachable, because fluocinolone acetonide ointment, we have used for many years.
Two acetic acid:
Following content is from Baidupedia.
http：／／baike.baidu.com／view／106631.htm
[administration explanation]
1. treatment tinea unguium, after sick first is clean with blade by medication after sick first skiving, note not contacting nail groove, fingernail proximate skin can be coated with skim vaseline and protect.
2. facial tinea is not with this product treatment.
3. high concentration glacial acetic acid has corrosiveness, except tinea unguium, does not do other tinea treatments.
4. treatment clavus and wart, before medication, diseased region is clean, and be immersed in hot water 15～30 minutes, contiguous normal skin is smeared protection with vaseline, then drips with medicine.
5[usage and consumption]
1. tinea unguium: be placed in disease first to be soaked with the cotton ball of 30% glacial acetic acid solution, every day 1 time, 1 time 10～15 minutes, until the removal of sick first, continual cure 2 weeks.
2. tinea manus and pedis: soak brothers with 10% glacial acetic acid solution, every day 1 time, 1 time 10 minutes, continuous 10 days, as not recovery from illness, can repeat 1 time every 1 week.
3. tinea versicolor: be coated with every day 2 times with 5% glacial acetic acid solution outward.
4. tinea corporis: wipe every day 2 times with 5%～10% glacial acetic acid solution outward.
5. clavus and wart: drip affected part, every day 1 time with 30% glacial acetic acid solution.
6. lavation wound surface: with 0.5%～2% solution.
[untoward reaction] can cause contact dermatitis.Glacial acetic acid solution treatment tinea unguium with 30% can cause chemical paronychia.Also there are twinge or burn feeling.
[contraindication] allergy and otitis media borer forbidding.
[2]
Toxicity: belong to lower toxicity
People prepare glacial acetic acid by the dry distilling of metal acetate salt.16 th Century German alchemist Andreas Li Bafeiwusi have just described this method, and take the glacial acetic acid being produced by this method come and compared by the acid of extracting in vinegar.Only because the existence of water caused the character of acetic acid that so large change occurs, to such an extent as in several centuries, chemists thinks that this is two distinct materials.French chemist A Di (Pierre Adet) proved they two be identical.
As above three problems of discussion explanation:
1 people are the highest by acetic acid treatment dermatosis concentration is 30%.
Acetic acid is also like this, acetic acid is below 50% concentration time, normal cell and sick cell to skin do not have selectivity, are homogeneous corrosion reactions, and acetic acid is in the time of high concentration, only sick cell is had to extremely strong permeability, normal cell is permeated hardly, and acetic acid is in the time that concentration is different, and character varies widely, utilize this character, we can complete the targeting medication to sick cell.
A time of reaction needed between 2 materials; in above-mentioned therapeutic process; in order to reach the response time, people coat vaseline around pathological changes, in order to protect normal skin; on the surface; be feasible, be actually out of the question, because the position of pathological changes is all irregular; normal skin also can be stained with acetic acid, and skin is damaged.
Because acetic acid is homogeneous corrosion in the time of low concentration, medication precisely very rambunctious accurately.
3 people have used for many years by low-concentration acetic acid treatment dermatosis.
Solution
In order to overcome the problems referred to above, the targeted drug that we are used, has done following design.
1 acetic acid is liquid, and vaseline is paste.
The concentration of 2 acetic acid is greater than 50%, and acetic acid and vaseline are separately to pack.
The using method of 3 these medicines is first to smear acetic acid, then smears vaseline.
4 when in use, all can add analgesic in vaseline and acetic acid.
The result of doing is like this:
1 because acetic acid is liquid, and we can suck acetic acid with a syringe, suck a certain amount of air simultaneously, grasp the part of air, utilize the principle of expanding with heat and contracting with cold of gas, and acetic acid is dripped to diseased region, realize the accurate as far as possible of medication.
2 because the concentration of acetic acid is greater than 50%, acetic acid permeability on normal skin and affected skin is variant, and what normal skin infiltrated lacks, and it is many that diseased region infiltrates, simultaneously in the time of high concentration, acetic acid can be very fast volatility, experimental results show that after 10 seconds of normal skin, high concentration acetic acid just volatilization is clean, residual quantity can not have injury to skin, and in the skin of diseased region, still have remaining acetic acid to exist, and remaining acetic acid has been enough to the targeting to sick cell.
Claims (4)
- The present invention relates to a kind of composite medicine, described medicine is the combination of acetic acid and vaseline, and compositions is all common drugs, as long as using method is correct, drug safety is reliable.1. dermatosis targeted drug according to claim 1, acetic acid is liquid, vaseline is paste.
- 2. dermatosis targeted drug according to claim 1, the concentration of acetic acid is greater than 50%, and acetic acid and vaseline are separately to pack.
- 3. dermatosis targeted drug according to claim 1, the using method of this medicine is first to smear acetic acid, then smears vaseline.
- 4. dermatosis targeted drug according to claim 1 when in use, all can add other medicines in vaseline and acetic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310353452.3A CN103830215A (en) | 2013-01-31 | 2013-08-04 | Skin-disease targeted medicine adopting acetic acid and vaseline as main components |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310036782.X | 2013-01-31 | ||
| CN201310036782 | 2013-01-31 | ||
| CN201310353452.3A CN103830215A (en) | 2013-01-31 | 2013-08-04 | Skin-disease targeted medicine adopting acetic acid and vaseline as main components |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103830215A true CN103830215A (en) | 2014-06-04 |
Family
ID=50794323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310353452.3A Pending CN103830215A (en) | 2013-01-31 | 2013-08-04 | Skin-disease targeted medicine adopting acetic acid and vaseline as main components |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103830215A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101108162A (en) * | 2007-08-16 | 2008-01-23 | 郭华岩 | Pharmaceutical composition treating ringworm of the nails, extremity tinea and method of manufacturing the same |
| CN101693040A (en) * | 2009-10-14 | 2010-04-14 | 许保通 | Medicament for treating onychomycosis and preparation method thereof |
| CN101703679A (en) * | 2009-11-10 | 2010-05-12 | 阚恭勇 | Medicament for treating onychomycosis |
-
2013
- 2013-08-04 CN CN201310353452.3A patent/CN103830215A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101108162A (en) * | 2007-08-16 | 2008-01-23 | 郭华岩 | Pharmaceutical composition treating ringworm of the nails, extremity tinea and method of manufacturing the same |
| CN101693040A (en) * | 2009-10-14 | 2010-04-14 | 许保通 | Medicament for treating onychomycosis and preparation method thereof |
| CN101703679A (en) * | 2009-11-10 | 2010-05-12 | 阚恭勇 | Medicament for treating onychomycosis |
Non-Patent Citations (2)
| Title |
|---|
| 《医学卫生普及全书》修订小组: "《医学卫生普及全书-皮肤科》", 31 May 1975, article "甲癣", pages: 27 * |
| 马振友: "《皮肤科国家基本药物与新特药手册》", 30 March 2000, 世界图书出版西安公司, article "冰醋酸溶液", pages: 419 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rozza et al. | The use of menthol in skin wound healing—Anti-inflammatory potential, antioxidant defense system stimulation and increased epithelialization | |
| CN102961282A (en) | Composition with penetration enhancing effect as well as preparation method and application thereof | |
| US20180369133A1 (en) | Ampk agonist topical medication for the treatment of certain specific medical conditions, methods of use thereof and wound dressing employing the same | |
| Anderson et al. | Salicylate poisoning potential of topical pain relief agents: from age old remedies to engineered smart patches | |
| Mousavi et al. | A clinical study of efficacy of garlic extract versus cryotherapy in the treatment of male genital wart | |
| Tian et al. | The regulatory effect of flavonoids extracted from Abutilon theophrasti leaves on gene expression in LPS-induced ALI mice via the NF-κB and MAPK signaling pathways | |
| CN102860303B (en) | Method for utilizing citriodora oil to extract waste liquid to prepare mosquito repellent | |
| Ocsel et al. | Effects of oriental sweet gum storax on porcine wound healing | |
| CN103830215A (en) | Skin-disease targeted medicine adopting acetic acid and vaseline as main components | |
| CN103751530A (en) | Extract of traditional Chinese medicine composite with anti-allergy effect, and application of extract | |
| CN102627545A (en) | Method for extracting paeonol | |
| Tatu et al. | Formulation, preparation, physico-chemical, microbiological analysis and clinical uses of capsaicin microemulsions | |
| CN103372131A (en) | Immersion liquid conducive to treatment of dermatophytosis, tinea pedis, foot odor and helosis | |
| CN108451816A (en) | A kind of inhibiting bacteria and diminishing inflammation acne-removing composition | |
| CN105796690B (en) | One kind treats psoriasic rose Chinese medicine composition and preparation method and application | |
| CN103610889B (en) | Nourishing the liver and kidney, keep fit supporing yang, improve the biofermentation preparation of sexual function | |
| CN107441071A (en) | A kind of application of ar-turmerone in treatment and/or prevention psoriasis is prepared | |
| CN102552771B (en) | Veterinary pure traditional Chinese medicine tincture for treating various intractable skin diseases | |
| CN101732288A (en) | Emulsifying agent for treating rabbit sarcoptidosis and killing mites in rabbit hutch | |
| Krstic et al. | Simultaneous Administration of Hyperbaric Oxygen Therapy and Antioxidant Supplementation with Filipendula ulmaria Extract in the Treatment of Thermal Skin Injuries Alters Nociceptive Signalling and Wound Healing | |
| CN103463185A (en) | Matched artemisia apiacea and agastache rugosaus combination medicine, preparation method and application thereof | |
| CN103550761A (en) | Cream for wound surface and preparation method thereof | |
| CN103638364A (en) | Medicament for treating anaphylaxis skin disease | |
| RU2522959C1 (en) | Keratoma removal technique | |
| CN101757078B (en) | Compound poultice for treating mumps and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140604 |